Opportunity Map catalyst · 2026-08-03 · version 1

    Curium to Acquire Lantheus in $8.0 Billion Radiopharm Deal

    Question

    Curium to Acquire Lantheus in $8.0 Billion Radiopharm Deal

    Direct answer

    M&A activity driving sector consolidation and immediate price action in LNTH. — bullish pressure on LNTH via acquisition at premium.

    Original publisher
    Market Ontology
    Evidence through
    2026-08-03
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Curium to Acquire Lantheus in $8.0 Billion Radiopharm Deal”, revision 1, evidence through 2026-08-03. https://marketontology.com/catalysts/2026-08-03/curium-to-acquire-lantheus-in-8-0-billion-radiopharm-deal-f65e92

    AssetDirectionTimeframeChannelScore
    LNTH▲BullIntradayacquisition at premium
    60
    Catalyst Driven·Healthcare·Corporate·expired

    Curium to Acquire Lantheus in $8.0 Billion Radiopharm Deal

    Thesis

    M&A activity driving sector consolidation and immediate price action in LNTH. — bullish pressure on LNTH via acquisition at premium.

    $102.50 per share cash offer.

    Transmission path
    01 · Catalyst
    Curium to Acquire Lantheus in $8.0 Billion Radiopharm Deal
    02 · Mechanism
    M&A activity driving sector consolidation and immediate price action in LNTH.
    03 · Asset response
    bullish pressure on LNTH
    Source evidence
    • Source$102.50 per share cash offer.
    • TransmissionM&A activity driving sector consolidation and immediate price action in LNTH.
    • SummarySignificant premium for Lantheus shareholders. Radiopharmaceuticals remain a high-conviction M&A theme in healthcare. CVR structure suggests some uncertainty regarding future pipeline milestones.
    Possible expressions
    • LNTHDirect directional exposure

    Illustrative, not advice

    Risks
    • Crowded positioning may already reflect the move
    • Counter-catalyst could neutralize the thesis before window closes
    Invalidation
    • LNTH closes below pre-catalyst level on rising volume
    • Catalyst narrative is officially walked back or contradicted
    • Cross-asset confirmation (rates / FX / vol) reverses direction
    Monitor
    • LNTH price vs. pre-event level
    • LNTH volume vs. 20-day average

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    Sources

    Related catalysts

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month